Status: Not yet recruiting
EUS-guided CTCs + Multi-omics: Predicting Pancreatic Cancer Recurrence and Metastases
The investigators conduct a single-center, prospective, observational study to explore the value of EUS-guided portal vein circulating tumor cells (PV-CTCs) and their subtypes combined with multi-omics tests in the early warning of recurrence and metastasis of resectable pancreatic cancer(RPC) and borderline resectable pancreatic cancer (BRPC).
Participants needed: 20
Trial details
Age: 18-70Biological sex: AllType: ObservationalSponsor: Huazhong University of Science and TechnologyUpdated: Mar 4, 2026Locations: 1Duration: 2 Years
Eligibility criteria
Patients with solid masses (diameter > 1 cm) in the pancreatic area within the a... [+4]
Patients with other active malignant tumors [+11]